Type 2 diabetes and Injection site vesicles

Summary:

Injection site vesicles is found among people with Type 2 diabetes, especially for people who are female, 60+ old.

The study analyzes which people have Injection site vesicles with Type 2 diabetes. It is created by eHealthMe based on reports of 167 people who have Type 2 diabetes from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Type 2 diabetes?

Type 2 diabetes is found to be associated with 1,431 drugs and 2,346 conditions by eHealthMe. Check the latest studies of Type 2 diabetes.

What is Injection site vesicles?

Injection site vesicles (fluid- or air-filled cavity or sac at injection site) is found to be associated with 299 drugs and 387 conditions by eHealthMe. Check the latest studies of Injection site vesicles.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

167 people who have Type 2 Diabetes and Injection Site Vesicles are studied.

Would you have Injection site vesicles when you have Type 2 diabetes?

Gender of people who have Type 2 diabetes and experienced Injection site vesicles *:

Click here to view

Age of people who have Type 2 diabetes and experienced Injection site vesicles *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Injection site vesicles?

- Check whether Injection site vesicles is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Type 2 diabetes (391,582 reports)
Injection site vesicles (5,489 reports)

All the drugs that are associated with Injection site vesicles:

Injection site vesicles (299 drugs)

All the conditions that are associated with Injection site vesicles:

Injection site vesicles (387 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Injection site vesicles and Type 2 diabetes, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.